(S)-2-Amino-4-((N-(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-4-chlorophenyl)sulfonamido)butanoic acid

ID: ALA5268138

Chembl Id: CHEMBL5268138

Max Phase: Preclinical

Molecular Formula: C20H24ClN7O7S

Molecular Weight: 541.97

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC[C@H](N)C(=O)O)S(=O)(=O)c2ccc(Cl)cc2)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C20H24ClN7O7S/c21-10-1-3-11(4-2-10)36(33,34)27(6-5-12(22)20(31)32)7-13-15(29)16(30)19(35-13)28-9-26-14-17(23)24-8-25-18(14)28/h1-4,8-9,12-13,15-16,19,29-30H,5-7,22H2,(H,31,32)(H2,23,24,25)/t12-,13+,15+,16+,19+/m0/s1

Standard InChI Key:  PCVJSFMEGWHQGZ-BPAMBQHCSA-N

Alternative Forms

  1. Parent:

    ALA5268138

    ---

Associated Targets(Human)

TRDMT1 Tbio tRNA (cytosine(38)-C(5))-methyltransferase (277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.97Molecular Weight (Monoisotopic): 541.1146AlogP: -0.83#Rotatable Bonds: 9
Polar Surface Area: 220.01Molecular Species: ZWITTERIONHBA: 12HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.23CX Basic pKa: 9.09CX LogP: -3.25CX LogD: -3.26
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: -0.07

References

1. Schwickert M, Zimmermann RA, Habeck T, Hoba SN, Nidoieva Z, Fischer TR, Stark MM, Kersten C, Lermyte F, Helm M, Schirmeister T..  (2023)  Covalent S-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead.,  14  (6): [PMID:37312859] [10.1021/acsmedchemlett.3c00062]

Source